Connexin43 interacts with Caveolin-3 in the heart

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 1685-1691

  Liu, Limei ^a   Li, Yuguang ^a   Lin, Jijin ^a,b   Liang, Qing ^a   Sheng, Xiuzhang ^a   Wu, Jun ^a   Huang, Ruiyan ^a   Liu, Shukai ^a   Li, Yanyan ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Caveolin 3; Connexin43; Gap junctions; Protein protein interaction; Yeast two hybrid

Indexed keywords

CAVEOLIN 3; CONNEXIN 43; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; GAP JUNCTION; HEART; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST; GENETICS; HEART MUSCLE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN TRANSPORT;

BASE SEQUENCE; CAVEOLIN 3; CONNEXIN 43; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; MYOCARDIUM; PLASMIDS; PROTEIN BINDING; PROTEIN TRANSPORT; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77953151536     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9584-5     Document Type: Article

References (25)

1. Goldberg GS, Moreno AP, Lampe PD (2002) Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J Biol Chem 277:36725-36730. doi:10.1074/jbc.M109797200
2. Saffitz JE, Laing JG, Yamada KA (2000) Connexin expression and turnover: implications for cardiac excitability. Circ Res 86:723-728
3. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI (2001) Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88:333-339
4. Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, Squarcioni CP, McKenna WJ, Thiene G, Basso C, Brousse N, Fontaine G, Saffitz JE (2004) Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 1:3-11. doi:10.1016/j.hrthm.2004.01.001
5. Carvajal-Huerta L (1998) Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol 39:418-421. doi:10.1016/S0190-9622(98)70317-2
6. Smith JH, Green CR, Peters NS, Rothery S, Severs NJ (1991) Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol 139:801-821
7. Dupont E, Matsushita T, Kaba RA, Vozzi C, Coppen SR, Khan N, Kaprielian R, Yacoub MH, Severs NJ (2001) Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol 33:359-371. doi:10.1006/jmcc.2000.1308
8. Peters NS, Green CR, Poole-Wilson PA, Severs NJ (1993) Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 88:864-875
9. Daleau P, Boudriau S, Michaud M, Jolicoeur C, Kingma JG Jr (2001) Preconditioning in the absence or presence of sustained ischemia modulates myocardial Cx43 protein levels and gap junction distribution. Can J Physiol Pharmacol 79:371-378. doi:10.1139/cjpp-79-5-371
10. Peters NS, Coromilas J, Severs NJ, Wit AL (1997) Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95:988-996
11. Matsumoto M, Hsieh TY, Zhu N, VanArsdale T, Hwang SB, Jeng KS, Gorbalenya AE, Lo SY, Ou JH, Ware CF, Lai MM (1997) Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 71:1301-1309
12. Lin J, Friesen MT, Bocangel P, Cheung D, Rawszer K, Wigle JT (2005) Characterization of Mesenchyme Homeobox 2 (MEOX2) transcription factor binding to RING finger protein 10. Mol Cell Biochem 275:75-84. doi:10.1007/s11010-005- 0823-3
13. Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, Lisanti MP (1998) Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet 63:1578-1587. doi:10.1086/302172
14. Okamoto T, Schlegel A, Scherer PE, Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422. doi:10.1074/jbc.273.10.5419
15. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261. doi:10.1074/jbc.271.4.2255
16. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP (1996) Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93:131-135. doi:10.1073/pnas.93.1.131
17. Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M, Bermudez J, Pedemonte M, Weidenheim KM, Pestell RG, Minetti C, Lisanti MP (2000) Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci USA 97:9689-9694. doi:10.1073/ pnas.160249097
18. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271:22810-22814. doi:10. 1074/jbc.271.37.22810
19. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA, Michel T (1998) Modulation of the endothelial nitric-oxide synthasecaveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem 273:30249-30254. doi:10.1074/jbc.273.46.30249
20. Venema VJ, Ju H, Zou R, Venema RC (1997) Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272:28187-28190. doi:10.1074/jbc.272.45.28187
21. Aravamudan B, Volonte D, Ramani R, Gursoy E, Lisanti MP, London B, Galbiati F (2003) Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype. Hum Mol Genet 12:2777-2788. doi:10.1093/hmg/ddg313
22. Bossuyt J, Taylor BE, James-Kracke M, Hale CC (2002) The cardiac sodium-calcium exchanger associates with caveolin-3. Ann N Y Acad Sci 976:197-204
23. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, KampTJ, Towbin JA (2006) Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114:2104-2112. doi:10.1161/CIRCULATIONAHA.106.635268
24. Schubert AL, Schubert W, Spray DC, Lisanti MP (2002) Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 41:5754-5764. doi:10.1021/bi0121656
25. Saliez J, Bouzin C, Rath G, Ghisdal P, Desjardins F, Rezzani R, Rodella LF, Vriens J, Nilius B, Feron O, Balligand JL, Dessy C (2008) Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2? signals and gap junction function are regulated by caveolin in endothelial cells. Circulation 117:1065-1074. doi:10.1161/CIRCULATIONAHA. 107.731679